Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem(Northwestern University), Mary F. Mulcahy(Northwestern University), James Carr(Northwestern University), Al B. Benson(Northwestern University), Bassel Atassi(Society of Interventional Radiology), Khairuddin Memon(Northwestern University), Robert J. Lewandowski(Society of Interventional Radiology), Scott A. Resnick(Northwestern University), Paul Nikolaidis(Northwestern University), Reed A. Omary(Vanderbilt University), Howard B. Chrisman(Northwestern University), Richard Chen(Personalis (United States)), Robert L. Vogelzang(Northwestern Medicine), Robert K. Ryu(University of Colorado Anschutz Medical Campus), Michaël Abécassis(University of Arizona), Vahid Yaghmai(Virginia Commonwealth University Medical Center), Ramona Gupta(Northwestern Memorial Hospital), Ahsun Riaz(Northwestern University), Frank H. Miller(Northwestern University), Laura Kulik(Northwestern University), Edward Wang, Saad Ibrahim(Northwestern Memorial Hospital), Albert A. Nemcek(Northwestern Medicine), Kent T. Sato(Society of Interventional Radiology), Steven B. Newman(Northwestern Memorial Hospital), Talia Baker(University of Utah), Seanthan Senthilnathan(Northwestern University), Vanessa L. Gates(Society of Interventional Radiology)
Cited by 649
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k